Search

Search Constraints

You searched for: Author/Creator Ding, Kevin

Search Results

1. 171 Secukinumab provides sustained PASDAS related low disease activity in psoriatic arthritis: two year results from the FUTURE 2 study. (25th April 2018)

3. Age and gender considerations on the symptomology in patients with superior semicircular canal dehiscence: A systematic review and case illustration. (July 2019)

4. Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial. Issue 10235 (9th May 2020)